Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.65 |
| ▸ | NPC1 | O15118 | 5/20 | 0.65 |
| ▸ | RAB9A | P51151 | 5/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.65 |
| ▸ | HTT | P42858 | 3/20 | 0.65 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.65 |
| ▸ | LMNA | P02545 | 4/20 | 0.54 |
| ▸ | MITF | O75030 | 1/20 | 0.54 |
| ▸ | NSD2 | O96028 | 1/20 | 0.54 |
| ▸ | ATM | Q13315 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 6/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | PKM | P14618 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.47 |
| ▸ | XBP1 | P17861 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10977632 | 1.00 | MAPT (0.65) | MAPTNPC1RAB9AMAPK1HTT | |
| SCHEMBL10977635 | 1.00 | MAPT (0.65) | MAPTNPC1RAB9AMAPK1HTT | |
| SCHEMBL15436912 | 0.84 | MAPT (0.67) | MAPTNPC1RAB9AMAPK1HTT | |
| SCHEMBL9006499 | 0.83 | MAPT (0.47) | MAPTNPC1RAB9AMAPK1HTT | |
| SCHEMBL9006491 | 0.83 | MAPT (0.47) | MAPTNPC1RAB9AMAPK1HTT | |
| SCHEMBL9448683 | 0.82 | MAPT (0.65) | MAPTNPC1RAB9AMAPK1HTT | |
| SCHEMBL9448690 | 0.82 | MAPT (0.65) | MAPTNPC1RAB9AMAPK1HTT | |
| SCHEMBL17899528 | 0.82 | MAPT (0.65) | MAPTNPC1RAB9AMAPK1HTT | |
| SCHEMBL14012043 | 0.81 | MAPT (0.69) | MAPTNPC1RAB9AMAPK1HTT | |
| SCHEMBL16807421 | 0.81 | MAPT (0.69) | MAPTNPC1RAB9AMAPK1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11780790-B2 | Organic light emitting device, crosslinking agent compound for organic light emitting device and manufacturing method of the organic light emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-10-10 | — | — | US | disclosed |
| EP-3941167-A1 | THIN METAL ELECTRODE FILMS, AND MANUFACTURING METHOD THEREOF | BASF SE (DE) | 2022-01-19 | — | — | EP | disclosed |
| US-20210347714-A1 | ORGANIC LIGHT EMITTING DEVICE, CROSSLINKING AGENT COMPOUND FOR ORGANIC LIGHT EMITTING DEVICE AND MANUFACTURING METHOD OF THE ORGANIC LIGHT EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-11-11 | — | — | US | disclosed |
| US-20210226142-A1 | UV CROSSLINKING OF PVDF-BASED POLYMERS FOR GATE DIELECTRIC INSULATORS OF ORGANIC THIN-FILM TRANSISTORS | CORNING INCORPORATED | 2021-07-22 | — | — | US | disclosed |
| US-20200203612-A1 | AZIDE-BASED COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE AZIDE-BASED COMPOUND, AND METHOD OF MANUFACTURING THE ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-06-25 | — | — | US | disclosed |
| US-10415011-B2 | Adherend recovery method, adherend recovery apparatus, gas-generating film and resin composition | JSR CORPORATION (JP) | 2019-09-17 | — | — | US | disclosed |
| US-10300477-B2 | Terminally-crosslinked methyl morpholinium-functionalized block copolymers, and anion exchange membranes using the same | INCHEON UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION (KR) | 2019-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11780790-B2 | Organic light emitting device, crosslinking agent compound for organic light emitting device and manufacturing method of the organic light emitting device | CYBA, AOX1, GJA1 | MAPT 904/4885NPC1 1964/4885RAB9A 2798/4885 |
| US-20210347714-A1 | ORGANIC LIGHT EMITTING DEVICE, CROSSLINKING AGENT COMPOUND FOR ORGANIC LIGHT EMITTING DEVICE AND MANUFACTURING METHOD OF THE ORGANIC LIGHT EMITTING DEVICE | CYBA, AOX1, GJA1 | MAPT 904/4885NPC1 1964/4885RAB9A 2798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.